Surgical intervention plays an important role in the diagnosis, staging, and treatment of
malignant pleural mesothelioma (MPM) and can be applied with curative or palliative intent …

Background Asbestos is a harmful and exceptionally persistent natural material. Malignant
mesothelioma (MM), an asbestos-related disease, is an insidious, lethal cancer that is poorly …

Diffuse pleural mesothelioma (DPM) is a lethal cancer with a poor prognosis and limited
treatment options. The Hippo signaling pathway genes, such as NF2 and LATS1/2, are …

Malignant pleural effusions, arising from either primary mesotheliomas or secondary
malignancies, heralds advanced disease and poor prognosis. Current treatments, including …

Purpose: The clinical standard treatment for patients with malignant pleural mesothelioma
(MPM) includes a cisplatin-based chemotherapy, leading to reduction of tumor size in only a …

Malignant pleural mesothelioma (MPM) is a rare cancer originated from pleural mesothelial
cells. MPM has been associated with long-term exposure to asbestos. The prognosis of …

Objective We changed our surgical approach to malignant pleural mesothelioma (MPM) in
August 2011 and adopted pleurectomy and decortication (PD) instead of extrapleural …

Malignant pleural mesothelioma (MPM) is a rare, but severe form of cancer, with an
incidence that varies significantly within and among different countries around the world. It …

Despite advances in malignant pleural mesothelioma therapy, life expectancy of affected
patients remains short. The limited efficiency of treatment options is mainly caused by inter …

Malignant pleural mesothelioma is a poorly treated neoplasia arising from the pleural
mesothelial lining. Here we document that the leaf extract of Cynara scolymus exerts broad …